Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-26-338121
Filing Date
2026-08-06
Accepted
2026-08-06 16:23:01
Documents
15
Effectiveness Date
2026-08-06

Document Format Files

Seq Description Document Type Size
1 S-8 d73385ds8.htm S-8 50757
2 EX-5.1 d73385dex51.htm EX-5.1 15268
3 EX-23.1 d73385dex231.htm EX-23.1 2527
4 EX-FILING FEES d73385dexfilingfees.htm   iXBRL EX-FILING FEES 16035
5 GRAPHIC g73385g0730065707175.jpg GRAPHIC 2216
6 GRAPHIC g73385g33w61.jpg GRAPHIC 8265
  Complete submission text file 0001193125-26-338121.txt   227565

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT d73385dexfilingfees_htm.xml XML 7518
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

EIN.: 273521219 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-298059 | Film No.: 261249503
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)